June 4, 2013
3:00 pm to 4:00 pm EDT

Sponsored by

Symposium Course Description:

Today, over 3000 molecular diagnostic (MDx) tests are marketed for clinical use and new diagnostics are regularly emerging at a rate of several per month. No standardized system for uniquely identifying these tests or capturing and analyzing the clinical and financial impact of individual tests currently exists. This course will show how the coordinated effort between the AMA and McKesson will bring specificity to the use, identification, reporting and tracking of MDx tests. This coordinated process will help to improve communication and collaboration between clinicians, hospitals, labs and payers.

Learning Objectives:

  • Analyze the benefits of molecular diagnostic test indexing and mapping for:
    • Payers
    • Laboratories
    • Physicians
    • Patients
    • Industry Stakeholders
  • Review how this new mapping of molecular diagnostic tests will work
  • Understand how to participate in the mapping process

Who Should Attend:

  • Payers (Utilization managers, network managers, care management)
  • Medical directors with oversight for genetic, molecular, and advanced diagnostic testing
  • Laboratories involved in molecular diagnostic testing and billing
  • Molecular diagnostic stakeholders

Program Agenda:

  • Introduction (3 minutes)
  • Molecular Diagnostic Industry Challenge (10 minutes)
  • Reviewing the benefits of molecular diagnostic test specificity (10 minutes)
  • AMA/McKesson relationship (10 minutes)
  • Review of new mapping process (10 minutes)
  • Summary (5 minutes)
  • Q&A (12 minutes)

Speaker Information:

Matthew ZubillerMatthew Zubiller
Vice President
McKesson Health Solutions

Matthew Zubiller is vice president for McKesson’s Decision Management business. He leads the company’s evidence-based decision support and personalized medicine initiatives, areas that promise to change the paradigm for healthcare practice and delivery. Responsible for McKesson’s flagship InterQual product line and its Clear Coverage SaaS based decision support platform, he drives operations, strategy, and product development for the business. He is a frequent speaker and author on topics such as next generation exception-based utilization management, decision support, and public policy for molecular and genetic testing.

Previously, he created and ran McKesson’s Advanced Diagnostics Management business and was part of the corporate strategy team. His background includes diagnostics, healthcare, enterprise software, global strategy consulting and M&A.

Recognized for his innovation, Mr. Zubiller was voted to Healthspottr’s “The Future of Health 100” list (ranked #49). Mr. Zubiller is a leading voice and thinker helping to usher in a new collaborative era of healthcare where stakeholders work together to develop and deploy connected decision management solutions that benefit all stakeholders by optimizing decision-making at all points of care.

Mr. Zubiller’s academic credentials include a Bachelor of Science in Economics (BSE) from the Wharton School, University of Pennsylvania, an MBA from the London Business School, and a certificate in Management of Technology jointly from the University of California, Berkeley’s HAAS School of Business and the College of Engineering. He enjoys spending his free time with his wife, Love and two young children, Texas and India.

Robert MusacchioRobert A. Musacchio
Senior Vice President, Business Products and Services
American Medical Association
Business: (312) 464-4324
Cell: (312) 408-5065

Robert A. Musacchio, PhD, is senior vice president of business products and services for the American Medical Association (AMA). In this role, he is responsible for all of the association's business activities and coding and nomenclature initiatives, including Current Procedural Terminology (CPT). Dr. Musacchio serves as chairman of the board of the AMA Insurance Agency, as an advisor to the American College of Cardiology's Business Development Strategic Advisory Panel, and as vice president of the board for Amagine, an AMA subsidiary that provides web-based clinical, patient, and practice support solutions designs by physicians, for physicians. Dr. Musacchio received his bachelor’s degree in economics from the State University of New York and his PhD in economics from the University of Wisconsin. Since 1978, Dr. Musacchio has published a number of papers on economics, healthcare, and information technology. His current areas of concentration within the AMA include a strategic assessment of the value of AMA membership and expansion of the reach of AMA business lines through new product development and innovation, along with publishing operations and initiatives.

Jay Ahlman
Vice President of Physician Practice Solutions
American Medical Association
Phone: 312-464-422

Jay Ahlman has over 20 years of healthcare experience, focusing on coding and reimbursement strategies and process improvement. In his current role as Vice President of Physician Practice Solutions for the AMA, he oversees the overall production and maintenance of the Current Procedural Terminology (CPT®) code set and manages the operations of the CPT Editorial Panel. Since joining the AMA in 1999, Jay has held various roles in business operations and business development for the Association